<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2983">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04353583</url>
  </required_header>
  <id_info>
    <org_study_id>AZ 58/20</org_study_id>
    <nct_id>NCT04353583</nct_id>
  </id_info>
  <brief_title>Renal Outcome in Patients With COVID-19</brief_title>
  <official_title>Renal Outcome in Patients With Coronavirus Disease 2019 (COVID-19)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Giessen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Giessen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute kidney injury (AKI) is reported to occur in 0.5-9% of severe acute respiratory distress
      coronavirus 2-positive patients and AKI has been identified as an independent risk factor for
      in-hospital mortality. The present study aims to investigate the incidence of renal outcome
      of in-hospital patients diagnosed with COVID-19.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Beginning in December 2019, a novel coronavirus, designated as severe acute respiratory
      distress coronavirus 2 (SARS-CoV-2), has caused an international outbreak of respiratory
      illness termed coronavirus disease 2019 (COVID-19). Although the clinical manifestations of
      COVID-19 are dominated by respiratory symptoms, some patients show severe kidney
      abnormalities. Acute kidney injury (AKI) is reported to occur in 0.5-9% of SARS-CoV-2
      positive patients and AKI has been identified as an independent risk factor for in-hospital
      mortality. The present study aims to investigate the incidence of of renal outcome of
      in-hospital patients diagnosed with COVID-19.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>Incidence of AKI</measure>
    <time_frame>Within 7 days after admission</time_frame>
    <description>As determined by Kidney Disease: Improving Global Outcomes (KDIGO) criteria</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Renal function changes during hospital stay</measure>
    <time_frame>from hospital admission til discharge up to 3 months</time_frame>
    <description>Serial biomarker assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of chronic kidney disease</measure>
    <time_frame>3 months post-hospital admission</time_frame>
    <description>As determined by KDIGO criteria</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Acute Kidney Injury</condition>
  <condition>Corona Virus Infection</condition>
  <arm_group>
    <arm_group_label>ICU patients</arm_group_label>
    <description>Patients with COVID-19 requiring ICU care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-ICU patients</arm_group_label>
    <description>In-hospital patients with COVID-19 not requiring ICU care</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diagnosed COVID-19
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with COVID-19 diagnosed by World Health Organisation (WHO) criteria

        Exclusion Criteria:

          -  Patients aged less than 18 years

          -  Patients with stage-5 chronic kidney disease

          -  Patients receiving maintenance dialysis

          -  Recipients of solid-organ transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Werner Seeger, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Giessen and Marburg, Giessen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Faeq Husain-Syed, MD</last_name>
    <phone>+49 641 985 42378</phone>
    <email>faeq.husain-syed@innere.med.uni-giessen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Horst-Walter Birk, MD</last_name>
    <phone>+49 641 985 42378</phone>
    <email>horst-walter.birk@innere.med.uni-giessen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Giessen and Marburg, Giessen</name>
      <address>
        <city>Giessen</city>
        <state>Hessen</state>
        <zip>35382</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020 May;97(5):824-828. doi: 10.1016/j.kint.2020.03.001. Epub 2020 Mar 7.</citation>
    <PMID>32204907</PMID>
  </results_reference>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>September 29, 2020</last_update_submitted>
  <last_update_submitted_qc>September 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

